• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤相关应激调节髓系来源抑制细胞的功能可塑性。

Tumor-related stress regulates functional plasticity of MDSCs.

机构信息

Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

Department of Immunology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.

出版信息

Cell Immunol. 2021 May;363:104312. doi: 10.1016/j.cellimm.2021.104312. Epub 2021 Feb 12.

DOI:10.1016/j.cellimm.2021.104312
PMID:33652258
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8026602/
Abstract

Myeloid-derived suppressor cells (MDSCs) impair protective anti-tumor immunity and remain major obstacles that stymie the effectiveness of promising cancer therapies. Diverse tumor-derived stressors galvanize the differentiation, intra-tumoral expansion, and immunomodulatory function of MDSCs. These tumor-associated 'axes of stress' underwrite the immunosuppressive programming of MDSCs in cancer and contribute to the phenotypic/functional heterogeneity that characterize tumor-MDSCs. This review discusses various tumor-associated axes of stress that direct MDSC development, accumulation, and immunosuppressive function, as well as current strategies aimed at overcoming the detrimental impact of MDSCs in cancer. To better understand the constellation of signals directing MDSC biology, we herein summarize the pivotal roles, signaling mediators, and effects of reactive oxygen/nitrogen species-related stress, chronic inflammatory stress, hypoxia-linked stress, endoplasmic reticulum stress, metabolic stress, and therapy-associated stress on MDSCs. Although therapeutic targeting of these processes remains mostly pre-clinical, intercepting signaling through the axes of stress could overcome MDSC-related immune suppression in tumor-bearing hosts.

摘要

髓系来源的抑制细胞(MDSCs)损害保护性抗肿瘤免疫,仍然是阻碍有前途的癌症治疗效果的主要障碍。各种肿瘤来源的应激源激发 MDSC 的分化、肿瘤内扩增和免疫调节功能。这些与肿瘤相关的“应激轴”为癌症中 MDSC 的免疫抑制编程提供了基础,并导致了肿瘤-MDSC 的表型/功能异质性。这篇综述讨论了各种与肿瘤相关的应激轴,这些应激轴直接指导 MDSC 的发育、积累和免疫抑制功能,以及目前旨在克服 MDSC 在癌症中不良影响的策略。为了更好地理解指导 MDSC 生物学的信号组合,我们在此总结了与活性氧/氮物种相关的应激、慢性炎症应激、缺氧相关应激、内质网应激、代谢应激和治疗相关应激相关的关键作用、信号介质和效应在 MDSCs 上。尽管这些过程的治疗靶向主要处于临床前阶段,但通过应激轴阻断信号可以克服肿瘤宿主中与 MDSC 相关的免疫抑制。

相似文献

1
Tumor-related stress regulates functional plasticity of MDSCs.肿瘤相关应激调节髓系来源抑制细胞的功能可塑性。
Cell Immunol. 2021 May;363:104312. doi: 10.1016/j.cellimm.2021.104312. Epub 2021 Feb 12.
2
Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer.慢性病毒感染和癌症中髓系来源的抑制性细胞群体受不同机制调控。
J Clin Invest. 2021 Aug 16;131(16). doi: 10.1172/JCI145971.
3
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease.内质网应激介导与癌症和传染病相关的髓系来源的免疫抑制。
J Transl Med. 2023 Jan 2;21(1):1. doi: 10.1186/s12967-022-03835-4.
4
Endoplasmic reticulum stress induced LOX-1 CD15 polymorphonuclear myeloid-derived suppressor cells in hepatocellular carcinoma.内质网应激诱导肝癌中 LOX-1+CD15+ 多形核髓源性抑制细胞。
Immunology. 2018 May;154(1):144-155. doi: 10.1111/imm.12876. Epub 2017 Dec 21.
5
Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing mice.血清抑制了来自荷 4T1 肿瘤小鼠的髓源抑制性细胞的免疫抑制功能。
Cancer Immunol Immunother. 2012 May;61(5):643-54. doi: 10.1007/s00262-011-1125-0. Epub 2011 Oct 22.
6
A common approach for fighting tuberculosis and leprosy: controlling endoplasmic reticulum stress in myeloid-derived suppressor cells.对抗结核病和麻风病的常见方法:控制髓源抑制性细胞中的内质网应激。
Immunotherapy. 2021 Dec;13(18):1555-1563. doi: 10.2217/imt-2021-0197. Epub 2021 Nov 8.
7
Accumulation of LOX-1 PMN-MDSCs in nasopharyngeal carcinoma survivors with chronic hepatitis B might permit immune tolerance to epstein-barr virus and relate to tumor recurrence.LOX-1 PMN-MDSCs 在慢性乙型肝炎鼻咽癌幸存者中的积累可能允许对 EBV 产生免疫耐受,并与肿瘤复发有关。
Aging (Albany NY). 2020 Dec 3;13(1):437-449. doi: 10.18632/aging.202149.
8
Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.糖酵解通过预防活性氧介导的细胞凋亡来调节荷瘤宿主中髓源性抑制细胞的扩增。
Cell Death Dis. 2017 May 11;8(5):e2779. doi: 10.1038/cddis.2017.192.
9
Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.通过靶向脂肪酸转运蛋白 2 调节髓源性抑制细胞中的 ROS 增强抗 PD-L1 肿瘤免疫治疗。
Cell Immunol. 2021 Apr;362:104286. doi: 10.1016/j.cellimm.2021.104286. Epub 2021 Jan 19.
10
Asah2 Represses the p53-Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis.Asah2 通过抑制 p53-Hmox1 轴来保护髓源性抑制细胞免于铁死亡。
J Immunol. 2021 Mar 15;206(6):1395-1404. doi: 10.4049/jimmunol.2000500. Epub 2021 Feb 5.

引用本文的文献

1
Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumours.髓系祖细胞失调助长肿瘤中的免疫抑制性巨噬细胞。
Nature. 2025 Sep 10. doi: 10.1038/s41586-025-09493-y.
2
Unraveling the Complexities of Myeloid-Derived Suppressor Cells in Inflammatory Bowel Disease.解析炎症性肠病中髓源性抑制细胞的复杂性
Int J Mol Sci. 2025 Apr 2;26(7):3291. doi: 10.3390/ijms26073291.
3
m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy.m6A RNA甲基化:肿瘤免疫的关键调节因子及癌症免疫治疗的潜在靶点
J Transl Med. 2025 Feb 28;23(1):245. doi: 10.1186/s12967-025-06221-y.
4
PERK-Olating Through Cancer: A Brew of Cellular Decisions.PERK在癌症中发挥作用:一系列细胞决策
Biomolecules. 2025 Feb 8;15(2):248. doi: 10.3390/biom15020248.
5
Surface CD52, CD84, and PTGER2 mark mature PMN-MDSCs from cancer patients and G-CSF-treated donors.表面 CD52、CD84 和 PTGER2 标记来自癌症患者和 G-CSF 处理供体的成熟 PMN-MDSC。
Cell Rep Med. 2024 Feb 20;5(2):101380. doi: 10.1016/j.xcrm.2023.101380. Epub 2024 Jan 18.
6
Modulation of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment by Natural Products.天然产物对肿瘤微环境中髓源性抑制细胞的调控作用。
Arch Immunol Ther Exp (Warsz). 2023 Jul 6;71(1):17. doi: 10.1007/s00005-023-00681-0.
7
Galectin-9 and myeloid-derived suppressor cell as prognostic indicators for chronic lymphocytic leukemia.半乳糖凝集素-9 和髓源性抑制细胞作为慢性淋巴细胞白血病的预后指标。
Immun Inflamm Dis. 2023 May;11(5):e853. doi: 10.1002/iid3.853.
8
Control of immune cell function by the unfolded protein response.未折叠蛋白反应对免疫细胞功能的调控。
Nat Rev Immunol. 2023 Sep;23(9):546-562. doi: 10.1038/s41577-023-00838-0. Epub 2023 Feb 8.
9
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease.内质网应激介导与癌症和传染病相关的髓系来源的免疫抑制。
J Transl Med. 2023 Jan 2;21(1):1. doi: 10.1186/s12967-022-03835-4.
10
Carboplatin enhances lymphocyte-endothelial interactions to promote CD8 T cell trafficking into the ovarian tumor microenvironment.卡铂增强淋巴细胞-内皮细胞相互作用,促进 CD8 T 细胞向卵巢肿瘤微环境浸润。
Gynecol Oncol. 2023 Jan;168:92-99. doi: 10.1016/j.ygyno.2022.11.001. Epub 2022 Nov 18.

本文引用的文献

1
c-Rel Is a Myeloid Checkpoint for Cancer Immunotherapy.c-Rel 是癌症免疫疗法的髓系检查点。
Nat Cancer. 2020 May;1(5):507-517. doi: 10.1038/s43018-020-0061-3. Epub 2020 May 18.
2
Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy.淋巴耗竭化疗引发的反应性骨髓增生限制了过继性 T 细胞治疗的疗效。
Mol Ther. 2020 Oct 7;28(10):2252-2270. doi: 10.1016/j.ymthe.2020.06.025. Epub 2020 Jun 24.
3
Myeloid Cell-Derived Arginase in Cancer Immune Response.髓系细胞衍生的精氨酸酶在癌症免疫反应中的作用
Front Immunol. 2020 May 15;11:938. doi: 10.3389/fimmu.2020.00938. eCollection 2020.
4
A guide to cancer immunotherapy: from T cell basic science to clinical practice.癌症免疫疗法指南:从 T 细胞基础科学到临床实践。
Nat Rev Immunol. 2020 Nov;20(11):651-668. doi: 10.1038/s41577-020-0306-5. Epub 2020 May 20.
5
Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.癌症中髓源性抑制细胞功能的代谢调控。
Cells. 2020 Apr 18;9(4):1011. doi: 10.3390/cells9041011.
6
The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.未折叠蛋白反应介体 PERK 通过抑制 STING 信号转导来调控肿瘤中髓系细胞驱动的免疫抑制。
Immunity. 2020 Apr 14;52(4):668-682.e7. doi: 10.1016/j.immuni.2020.03.004.
7
Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs.肿瘤衍生的前列腺素 E2 促进单核细胞来源的 MDSC 的 p50 NF-κB 依赖性分化。
Cancer Res. 2020 Jul 1;80(13):2874-2888. doi: 10.1158/0008-5472.CAN-19-2843. Epub 2020 Apr 7.
8
The emerging role of myeloid-derived suppressor cells in radiotherapy.髓源性抑制细胞在放射治疗中的新作用。
Radiat Oncol J. 2020 Mar;38(1):1-10. doi: 10.3857/roj.2019.00640. Epub 2020 Mar 25.
9
Valproic acid attenuates CCR2-dependent tumor infiltration of monocytic myeloid-derived suppressor cells, limiting tumor progression.丙戊酸减弱单核细胞来源的髓系抑制细胞的CCR2依赖性肿瘤浸润,限制肿瘤进展。
Oncoimmunology. 2020 Feb 29;9(1):1734268. doi: 10.1080/2162402X.2020.1734268. eCollection 2020.
10
Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.髓源性抑制细胞作为癌症治疗靶点。
Cells. 2020 Feb 27;9(3):561. doi: 10.3390/cells9030561.